Reviewed by PillSeek Editorial Team · Last verified
Pill Identification
This is a Yellow Round pill with imprint 305;G, identified as Norethindrone 0.35 mg manufactured by Glenmark Generics Inc., USA. It is supplied as Unknown and distributed under NDC 68462-0305-84.
What it's used for
Source: PillSeek editorial team
⚠️ What to verify before taking this medication
- Verify the imprint, color, and shape match exactly — even a single different character can mean a different drug.
- Check the expiration date on the original packaging.
- Look for signs of tampering, discoloration, or unusual odor.
- Confirm with your pharmacist or prescriber before taking any medication you are unsure about.
- Never take medication prescribed to someone else.
This is patient-safety guidance, not medical advice. Read full medical disclaimer.
Pill Specs
- Imprint
- 305;G
- Strength
- 0.35 mg
- Color
- Yellow
- Dosage Form
- Unknown
- Shape
- Round
- Route
- Oral
- Size
- 6 mm
- RxCUI
- 0
- DEA Schedule
- Schedule N/a
- Pharmacologic Class
- Contraceptives, progestogens
Medication Summary
No separate FDA Medication Guide was found for this label. Read a patient-friendly summary based on FDA/DailyMed prescribing information.
Read Medication Summary💰 Price
Price data unavailable for this NDC.
Similar-looking pills — double-check before taking
This pill looks similar to the following. Verify the imprint, color, and shape carefully before taking any medication.
Composition
- Active Ingredients
- Norethindrone
- Inactive Ingredients
- Silicon dioxide, corn starch, d&c yellow no. 10, ethylcellulose, lactose anhydrous, magnesium stearate, microcrystalline cellulose, povidone, magnesium silicate
Frequently Asked Questions
About this medication
- Manufacturer
- Glenmark Generics Inc., USA
- Status (Rx/OTC)
- Rx
- Brand Names
- Camila
- NDC Code
- 68462-0305-84
Data Sources
- DailyMed — Search DailyMed for NDC 68462-0305-84
- RxNorm — View in RxNav (RxCUI: 0)
Data last verified:
For educational use only. Always consult your pharmacist or doctor. Read disclaimer.